Literature DB >> 21997498

The impact of menopausal symptoms on work ability.

Marije Geukes1, Mariëlle P van Aalst, Mary C E Nauta, Henk Oosterhof.   

Abstract

OBJECTIVE: Menopause is an important life event that may have a negative influence on quality of life. Work ability, a concept widely used in occupational health, can predict both future impairment and duration of sickness absence. The aim of this study was to examine the impact of menopausal symptoms on work ability.
METHODS: This was a cross-sectional study that used a sample of healthy working Dutch women aged 44 to 60 years. Work ability was measured using the Work Ability Index, and menopausal symptoms were measured using the Greene Climacteric Scale. Stepwise multiple linear regression models were used to examine the relationship between menopausal symptoms and work ability.
RESULTS: A total of 208 women were included in this study. There was a significant negative correlation between total Greene Climacteric Scale score and Work Ability Index score. Total Greene Climacteric Scale score predicted 33.8% of the total variance in the Work Ability Index score. Only the psychological and somatic subscales of the Greene Climacteric Scale were significant predictors in multiple linear regression analysis. Together, they accounted for 36.5% of total variance in Work Ability Index score.
CONCLUSIONS: Menopausal symptoms are negatively associated with work ability and may increase the risk of sickness absence.

Entities:  

Mesh:

Year:  2012        PMID: 21997498     DOI: 10.1097/gme.0b013e31822ddc97

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   2.953


  9 in total

1.  Reproductive endocrinology: Hormone therapy to treat menopause--breaking a taboo.

Authors:  Susan R Davis
Journal:  Nat Rev Endocrinol       Date:  2013-10-29       Impact factor: 43.330

Review 2.  Treating menopause - MHT and beyond.

Authors:  Susan R Davis; Rodney J Baber
Journal:  Nat Rev Endocrinol       Date:  2022-05-27       Impact factor: 47.564

3.  Vitamin D levels and menopause-related symptoms.

Authors:  Erin S LeBlanc; Manisha Desai; Nancy Perrin; Jean Wactawski-Wende; JoAnn E Manson; Jane A Cauley; Yvonne L Michael; Jean Tang; Catherine Womack; Yiqing Song; Karen C Johnson; Mary J O'Sullivan; Nancy Woods; Marcia L Stefanick
Journal:  Menopause       Date:  2014-11       Impact factor: 2.953

4.  Short- and Long-term Effects of a Physical Exercise Intervention on Work Ability and Work Strain in Symptomatic Menopausal Women.

Authors:  Reetta Rutanen; Riitta Luoto; Jani Raitanen; Kirsi Mansikkamäki; Eija Tomás; Clas-Håkan Nygård
Journal:  Saf Health Work       Date:  2014-09-16

Review 5.  Continuous oral contraceptives versus long-term pituitary desensitization prior to IVF/ICSI in moderate to severe endometriosis: study protocol of a non-inferiority randomized controlled trial.

Authors:  L E E van der Houwen; M C I Lier; A M F Schreurs; M van Wely; P G A Hompes; A E P Cantineau; R Schats; C B Lambalk; V Mijatovic
Journal:  Hum Reprod Open       Date:  2019-02-23

Review 6.  Menopause and work: A narrative literature review about menopause, work and health.

Authors:  Petra Verdonk; Elena Bendien; Yolande Appelman
Journal:  Work       Date:  2022

7.  Management of osteoporosis and menopausal symptoms: focus on bazedoxifene/conjugated estrogen combination.

Authors:  Sebastian Mirkin; James H Pickar
Journal:  Int J Womens Health       Date:  2013-08-07

Review 8.  Menopausal symptoms and work: a narrative review of women's experiences in casual, informal, or precarious jobs.

Authors:  Heather Yoeli; Jane Macnaughton; Sarah McLusky
Journal:  Maturitas       Date:  2021-05-31       Impact factor: 4.342

9.  "I Get That Spirit in Me"-Mentally Empowering Workplace Health Promotion for Female Workers in Low-Paid Jobs during Menopause and Midlife.

Authors:  Marjolein Verburgh; Petra Verdonk; Yolande Appelman; Monique Brood-van Zanten; Karen Nieuwenhuijsen
Journal:  Int J Environ Res Public Health       Date:  2020-09-04       Impact factor: 3.390

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.